Literature DB >> 1302444

[Antitumor activities of 4 derivatives of artemisic acid and artemisinin B in vitro].

W C Sun1, J X Han, W Y Yang, D A Deng, X F Yue.   

Abstract

The cytotoxicities of 2 derivatives of artemisinin B and 2 derivatives of artemisic acid (designated as Compound A, B, C, and D) were investigated, using trypan blue dye exclusion test and colony-forming units assay. At the concentration of 5 micrograms.ml-1, the inhibition rates of these 4 compounds against murine leukemia cell line P388 were > 85%. When tested against human hepatoma cell line SMMC-7721 at 25 micrograms.ml-1, the inhibition rates of Compound A, B, C, and D were found to be 92.3%, 96.9%, 84%, and 82.1%, respectively, and 27%, 8%, 37.8%, 1.7% against normal human embryonic lung cell line WI-38, respectively. These 4 compounds all showed an inhibition rate of 100% against human gastric cancer cell line SGC-7901 at 50 micrograms.ml-1.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1302444

Source DB:  PubMed          Journal:  Zhongguo Yao Li Xue Bao        ISSN: 0253-9756


  8 in total

1.  pH-responsive artemisinin dimer in lipid nanoparticles are effective against human breast cancer in a xenograft model.

Authors:  Yitong J Zhang; Xi Zhan; Liguo Wang; Rodney J Y Ho; Tomikazu Sasaki
Journal:  J Pharm Sci       Date:  2015-03-09       Impact factor: 3.534

2.  Traditional Chinese medicine in the prevention and treatment of cancer and cancer metastasis.

Authors:  Lin Ye; Yongning Jia; K E Ji; Andrew J Sanders; Kan Xue; Jiafu Ji; Malcolm D Mason; Wen G Jiang
Journal:  Oncol Lett       Date:  2015-07-06       Impact factor: 2.967

Review 3.  Qinghaosu (artemisinin): chemistry and pharmacology.

Authors:  Ying Li
Journal:  Acta Pharmacol Sin       Date:  2012-08-27       Impact factor: 6.150

4.  Dihydroartemisinin inhibits the mammalian target of rapamycin-mediated signaling pathways in tumor cells.

Authors:  Yoshinobu Odaka; Baoshan Xu; Yan Luo; Tao Shen; Chaowei Shang; Yang Wu; Hongyu Zhou; Shile Huang
Journal:  Carcinogenesis       Date:  2013-08-08       Impact factor: 4.944

Review 5.  Progress in the research of artemisinin-related antimalarials: an update.

Authors:  H J Woerdenbag; N Pras; W van Uden; T E Wallaart; A C Beekman; C B Lugt
Journal:  Pharm World Sci       Date:  1994-08-05

Review 6.  Phytochemistry and pharmacological activity of the genus artemisia.

Authors:  Dheeraj Bisht; Deepak Kumar; Dharmendra Kumar; Kamal Dua; Dinesh Kumar Chellappan
Journal:  Arch Pharm Res       Date:  2021-04-24       Impact factor: 6.010

Review 7.  Artemisinin-Type Drugs in Tumor Cell Death: Mechanisms, Combination Treatment with Biologics and Nanoparticle Delivery.

Authors:  Xinyu Zhou; Fengzhi Suo; Kristina Haslinger; Wim J Quax
Journal:  Pharmaceutics       Date:  2022-02-10       Impact factor: 6.321

Review 8.  Antitumor Research on Artemisinin and Its Bioactive Derivatives.

Authors:  Yunqin Zhang; Guowei Xu; Shuqun Zhang; Dong Wang; P Saravana Prabha; Zhili Zuo
Journal:  Nat Prod Bioprospect       Date:  2018-04-09
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.